MGM China (02282) spent 4.9519 million Hong Kong dollars to repurchase 300,000 shares on November 13th.
MGM China (02282) announced that on November 13, 2025, the company spent 495.19...
MGM CHINA (02282) announced that on November 13, 2025, the company spent HK$4.9519 million to repurchase 300,000 shares, with a repurchase price of HK$16.33-16.63 per share.
Related Articles
Bivalent influenza vaccine Phase I clinical trial initiated, AB&B BIO-TECH-B (02627) vaccine pipeline continues to expand.
Dongguan Changlian New Materials Technology (301618.SZ) plans to reduce their total shareholding by no more than 4.37% by three shareholders.
ES SERVICES(01995) has allocated a total of 60.6 million subscription rights and plans to repurchase up to about 173 million shares.
Bivalent influenza vaccine Phase I clinical trial initiated, AB&B BIO-TECH-B (02627) vaccine pipeline continues to expand.
Dongguan Changlian New Materials Technology (301618.SZ) plans to reduce their total shareholding by no more than 4.37% by three shareholders.
ES SERVICES(01995) has allocated a total of 60.6 million subscription rights and plans to repurchase up to about 173 million shares.
RECOMMEND
Energy Storage Industry Set To Ride the AI Tailwind; UBS: Global Demand May Surge 40% Next Year
13/11/2025
Double Eleven’s Cooling To A Historic Low? A Necessary Step Toward E‑commerce Maturity
13/11/2025
On The Eve of L3 Mass Commercialization: How Autonomous Driving Will Reconfigure a Trillion‑Yuan Service Market
13/11/2025
